Know Your Real Payer Market Share — By State, By Product, By Plan
Resolve your existing payer contracts against a validated national enrollment dataset to see your actual market share and rank the biggest uncontracted opportunities by covered lives.
Why Diagnostics & Lab Companies Choose Medlyze
✓See your actual contracted market share by state and product line, not just a count of signed contracts
✓Rank the biggest uncontracted or under-penetrated payers by covered lives, down to the individual plan for Medicare Advantage and Medicaid
✓Validate the approach with a single-state pilot — fully credited toward your full rollout if you move forward
Solutions for Diagnostics & Lab Companies
Market Data Insights
Maximize revenue, reduce unit costs, and save teams 15+ hours per week with Payer and Hospital price transparency data and benchmarking that pays for itself.
Payer Contracting & Strategy
Build a data-driven negotiation strategy backed by price transparency benchmarks. We analyze your rate gaps, model upside scenarios, and deliver a ready-to-use playbook for your next payer negotiation.
Payer Network Coverage & Market Share Analysis
See your actual contracted market share by state and product, resolved directly against a validated national enrollment dataset — then get a ranked list of the contracting opportunities worth pursuing first.
Free Resources for Diagnostics & Lab Companies
Rates Search Tool
Interactive search functionality for healthcare rates and pricing data
View RatesLearn More: Free Implementation Guides
In-depth guides to help you understand the strategies behind these solutions
Why MA and Medicaid Enrollment Data Goes to the Plan Level (and Commercial Doesn't)
The regulatory reason commercial enrollment data never resolves below the legal entity
Read Guide →Payer Contract Intake Checklist for a Market Share Analysis
The exact fields a market share pilot needs from your contract list
Read Guide →MA and Managed Medicaid Enrollment by Plan, Not Just Carrier: An Arizona Example
Real, verified plan-level enrollment data down to individual brands and parent companies
Read Guide →What Our Clients Say
“Before working with Medlyze, we were struggling through payer negotiations with no visibility in market rates and little leverage to improve our low reimbursement rates. Medlyze provided the exact support we needed by exposing competitor rates and delivering a clear contract negotiation strategy, finally giving us the data to align our approach. Now, we are positioned to increase our rates with our current payer and have a replicable strategy for future contracts with companies like Cigna.”
Urology Practice Owner
Owner, Colorado Urology Practice
“This is Gold!”
Actuary
Actuary, BCBS Plan
“We thought our RCM team was doing a great job, and they were. But Medlyze found $1.8M in underpayments we'd completely missed. It's like having a forensic auditor who only gets paid when they find money. Zero risk for us, pure upside.”
CFO
Chief Financial Officer, Regional Hospital System
Frequently Asked Questions
It's built around your specific contract list, not a generic provider framing. Diagnostics, genetic testing, and lab companies contract with payers differently than a typical provider group, so we resolve your actual payer contracts against national enrollment data to show your real market share and biggest uncontracted opportunities, by state and product line.
Ready to Maximize Revenue, Reduce Costs, and Save Time?
See how Medlyze delivers measurable ROI for diagnostics & lab companies in 90 days or less